HarrisMartin's Webinar Series: The Elmiron MDL - Hear from the Leadership Counsel

Conference Agenda

Day 1, Friday, March 05, 2021

2:00 p.m. - 2:05 p.m.
Welcome

Virginia E. Anello, Douglas & London, P.C., New York
Rachel L. Shkolnik, Napoli Shkolnik PLLC, New York


2:05 p.m. - 2:20 p.m.
Elmiron: Important Updates on the MDL and Defendants

Virginia E. Anello, Douglas & London, P.C., New York


2:20 p.m. - 2:35 p.m.
The Science of the Drug and the Injury

Danielle Ward Mason, Sanders Phillips Grossman, LLC, Garden City, NY


2:35 p.m. - 2:50 p.m.
The Studies Linking Elmiron to the Signature Injury

Aimee H. Wagstaff, Andrus Wagstaff, Denver


2:50 p.m. - 3:05 p.m.
Liability and Marketing Issues

D. Nicole “Nikki” Guntner, Aylstock, Witkin, Kreis & Overholtz, PLLC, Pensacola, FL


3:05 p.m. - 3:20 p.m.
Case Selection Criteria Based on Science, Studies, Intake, and Case Evaluation

Rachel L. Shkolnik, Napoli Shkolnik PLLC, New York


3:20 p.m. - 3:30 p.m.
Roundtable Discussion of Any Issues that Are Unique to the Elmiron Litigation

Virginia E. Anello, Douglas & London, P.C., New York
Rachel L. Shkolnik, Napoli Shkolnik PLLC, New York
Aimee H. Wagstaff, Andrus Wagstaff, Denver
Danielle Ward Mason, Sanders Phillips Grossman, LLC, Garden City, NY
D. Nicole “Nikki” Guntner, Aylstock, Witkin, Kreis & Overholtz, PLLC, Pensacola, FL